Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
GlobeNewswire
SHANGHAI, China, April 24, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877;..
SHANGHAI, China, April 24, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877;..
· Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands..
The SaaS eDiscovery solution will provide more value in the cloud for Proxiio’s clients
GURUGRAM, India, April 24,..